Home | CRISPR Therapeutics | Website analytics by TrustRadar
Blurry colored background
crisprtx.com Biotechnology Pharmaceuticals Gene Editing Healthcare

Home | CRISPR Therapeutics

Home

CRISPR Therapeutics is a leading biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. The company is leveraging this technology to develop a broad portfolio of therapeutic programs across a range of disease areas including hemoglobinopathies, cancer, diabetes, and others.

Unique Visits

135K

4500 / day

Total Views

150K

5000 / day

Visit Duration, avg.

3.8 min

3.2 pages per visit

Bounce Rate

40%

  • Domain Rating

  • Domain Authority

  • Citation Level

Founded in

2013

Supported Languages

English, etc

Website Key Features

CRISPR/Cas9 Technology

Utilizes the groundbreaking CRISPR/Cas9 gene-editing technology for precise genomic modifications.

Therapeutic Programs

Develops a wide range of therapeutic programs targeting serious diseases such as hemoglobinopathies, cancer, and diabetes.

Research and Development

Invests heavily in R&D to discover and develop new gene-based medicines.

Clinical Trials

Conducts clinical trials to test the safety and efficacy of its gene-editing therapies.

Partnerships

Collaborates with leading academic institutions, biotech, and pharmaceutical companies to advance its research and development efforts.

Regulatory Expertise

Possesses deep regulatory expertise to navigate the complex approval processes for gene therapies.

Manufacturing Capabilities

Has state-of-the-art manufacturing facilities to produce gene-editing therapies at scale.

Patient Access Programs

Implements programs to ensure patients have access to its transformative therapies.

Global Presence

Operates globally with a presence in key markets to advance its mission of developing gene-based medicines.

Innovative Pipeline

Maintains a robust pipeline of innovative gene-editing therapies targeting a wide range of diseases.

Additional information

Headquarters

Zug, Switzerland

Key People

Samarth Kulkarni, Ph.D. (CEO), Rodger Novak, M.D. (Co-Founder)

Website

https://www.crisprtx.com

Contact Information

For more information, visit the official website or contact via the provided contact form.

Social Media

CRISPR Therapeutics is active on LinkedIn and Twitter, sharing updates and insights into their work and the field of gene editing.

Investor Relations

Provides detailed information for investors, including financial reports, presentations, and SEC filings.

Careers

Offers opportunities for professionals passionate about making a difference in the field of gene editing and biopharmaceuticals.

HTTP headers

Security headers report is a very important part of user data protection. Learn more about http headers for crisprtx.com